Treatment Research Institute > Our People > Board of Directors

Board of Directors

Photo of  Mary  Esteves MEd Mary Esteves MEd

Mary Esteves, MEd is President of Nova Consulting, Inc., an organization that helps well-run firms become extraordinary companies based on over 30 years of management and organizational consulting to heads of major corporations. A counseling psychologist with extensive management experience, Ms. Esteves is dedicated to helping executives attain excellence in their marketplace by optimizing their leadership and employee talent for greater productivity and profitability. Her expertise in organizational and job competency assessment; motivation and management training; and career planning, appraisal and development, spans national and international markets ranging from pharmaceutical, chemical, transportation and consumer products to telecommunication, computer, financial and advertising. Other distinguished consulting organizations she has led include Integra Consulting (President), a research-based organization dedicated to improving individual, group and organizational functioning; the Hay Group (Owner-Partner and Managing Director of its North and South America Human Resources Planning and Development Business Unit), dedicated to helping public and private sector groups attain competitive advantage through selection, appraisal and development of human resources; and McBer and Company (Officer and Senior Vice President) where she helped clients in numerous industries reduce product development cycle time and improve bottom-line results.

A published author on entrepreneurial innovation, organizational competencies, life and career planning, goal setting, values clarification, and organizational effectiveness for women, Ms. Esteves has also served as a psychologist and consultant to a community hospital and social services agency. She holds a Master’s Degree in Counseling Psychology and has pursued advanced education with National Training Laboratories and the Institute of Social Research at the University of Michigan, among other institutions.

Return to top.
Photo of  John  Kimberly PhD John Kimberly PhD

John Kimberly, Ph.D., is the Henry Bower Professor of Entrepreneurial Studies, Department of Management and Department of Health Care Management and Economics at The Wharton School, University of Pennsylvania and Distinguished Visiting Scholar at INSEAD in Fontainebleau, France. His research interests include health policy, institutional creation, managerial innovation, organization change and organizational design. He is a reviewer for, and also serves on the Editorial Boards of, several journals and is a consultant to a number of organizations in the public and private sectors including the Directorate for Science, Technology, and Industry, and Directorate for Scientific Affairs, Organization for Economic Cooperation and Development, Paris, France; Advisory Panel for the Office of Medical Technology, Office of Technology Assessment, U.S. Congress; Institute of Medicine, National Academy of Science; Association of American Medical Colleges; the Robert Wood Johnson Foundation, and the MacArthur Foundation. Dr. Kimberly writes widely on health care and health policy management, managerial and organizational innovation, and organizational development and change. Some of his current research includes “The Changing Landscape of Business Education and Research,” “The Business of Addiction Treatment,” and “The Structure and Impact of the Chief Innovation Officer Role”. He often serves as a Keynote speaker for international health policy, hospital and managerial meeting agendas. Dr. Kimberly received his B.A. in Sociology from Yale University; and his M.S. and Ph.D. in Organizational Behavior from Cornell University.

Return to top.
Kenneth A. Lynch CPA, MT

Kenneth A. Lynch, CPA, MT is Assistant Vice President for Financial Reporting and Risk Management at South Jersey Industries, Inc. He has 20 years of experience performing assurance services and advising companies on complex financial issues. Formerly a Senior Manager in the Entrepreneurial Services Group of Ernst and Young LLP, Ken has served a wide range of clients from closely held, emerging growth companies to multi-national, publicly traded entities. These clients have primarily been in the manufacturing, retail, distribution, software, service and technology industries. Ken has assisted numerous clients as they enter into significant transactions such as mergers, acquisitions and public offerings.

Return to top.
Photo of  Stephen J. McCormack PhD Stephen J. McCormack PhD

Stephen McCormack, PhD is passionate about the development of medical products, technologies, and services that address unmet medical need. He has had the good fortune to participate as an active executive, investor and board member to over two dozen companies in the industry (Exela.com). He has contributed to the development of numerous medical therapies and products across many areas of medicine. His scientific contributions and patents include delivery of drugs to the eye, medical devices for the treatment of tinnitus, allergy vaccines, and diagnostic tests for cervical cancer. For the past several years the advancement of mental health and substance abuse treatment has been part of these pursuits –in both the healthcare delivery aspects and through development supportive mobile health applications.

Dr. McCormack currently serves as Chairman of the Board of Directors and Chief Executive Officer of Visus Technology.  Visus is advancing mobile accessibility technology through the development cloud-based computer vision solutions for the elderly and visually impaired communities. Other companies that he co-founded and operated include: AlleCure, MannKind, NeuroSystec, CytoMx, Cynvenio, American Optical Services and Exela Hearing Services. He lived in Europe for four years and was a Managing Director at Global Life Science Ventures in Zug, Switzerland and the Chief Executive Officer of Intelligent Medical Implants in Bonn, Germany.

He has previously held academic positions at Georgetown University Medical Center, Rockefeller University, George Mason University and the UMMC and was part of the founding senior management at the Keck Graduate Institute. Dr. McCormack received his PhD in the Interdepartmental Biomolecular Science and Engineering program from University of California, Santa Barbara. He obtained a bachelor’s degree in biology from the College of the Holy Cross in Worcester, MA.

Return to top.
Photo of  A. Thomas  McLellan PhD A. Thomas McLellan PhD Board Chair

A. Thomas McLellan, Ph.D., Chair of the Board, is co-founder of the Treatment Research Institute (TRI) and an experienced substance abuse researcher. From 2009 to 2010, he was Science Advisor and Deputy Director of the White House Office of National Drug Control Policy (ONDCP), a Congressionally confirmed Presidential appointment to help shape the nation’s public policy approach to illicit drug use. At ONDCP, McLellan worked on a broad range of drug issues, including formulation and implementation of the President’s National Drug Control Strategy and promotion of drug treatment through the broader revamping of the national health care system. Dr. McLellan has more than 35 years of experience in addiction treatment research. In 1992, he co-founded and led (until his ONDCP appointment) TRI to transform the way research is employed in the treatment of and policy making around substance use and abuse. In his career he has published over 400 articles and chapters on addiction research. From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment, and he has also served on several other editorial boards of scientific journals. Dr. McLellan is the recipient of several distinguished awards including the Life Achievement Awards of the American and British Societies of Addiction Medicine (2001 & 2003); the Robert Wood Johnson Foundation Innovator Award (2005); and awards for Distinguished Contribution to Addiction Medicine from the Swedish (2002) and Italian (2002) Medical Associations. In the 1980s, with his colleagues from the Center for the Studies of Addiction at the University of Pennsylvania, Dr. McLellan introduced the Addiction Severity Index and, later, the Treatment Services Review. Both are among the most widely used assessment instruments in the world.

Return to top.
Photo of  Charles P. O’Brien MD, PhD Charles P. O’Brien MD, PhD

Charles P. O’Brien, MD, PhD is Chief of Psychiatry at the Philadelphia VA Medical Center, and Vice-Chair of Psychiatry at the University of Pennsylvania where he is also Director of the Center for Studies of Addiction. O’Brien was elected to the Institute of Medicine of the National Academy of Sciences in 1991, and has received numerous national research awards as well as an honorary Doctorate from the University of Bordeaux in 1994 and the Nathan P. Eddy award for research on addiction from the College on Problems of Drug Dependence. O’Brien’s research focus is on discovery of changes to the central nervous system involved in relapse, new medications, behavioral treatments, and instruments for measuring the severity of addictive disorders. He is past President of both the American College of Neuropsychopharmacology and the Association for Research in Nervous and Mental Disease.

Return to top.